Upfront multi‐bipolar radiofrequency ablation for HCC in transplant‐eligible cirrhotic patients with salvage transplantation in case of recurrence

We aim to assess the long‐term outcomes of percutaneous multi‐bipolar radiofrequency (mbpRFA) as the first treatment for hepatocellular carcinoma (HCC) in transplant‐eligible cirrhotic patients, followed by salvage transplantation for intrahepatic distant tumour recurrence or liver failure.

[1]  B. Sensi,et al.  Primary versus Salvage Liver Transplantation after Curative-Intent Resection or Radiofrequency Ablation for Hepatocellular Carcinoma: Long-Term Oncological Outcomes , 2023, Cancers.

[2]  J. Zucman‐Rossi,et al.  Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA , 2023, Cancers.

[3]  T. Reichman,et al.  Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort study , 2022, Annals of medicine and surgery.

[4]  P. Nahon,et al.  Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[5]  M. Cescon,et al.  The Role of Salvage Transplantation in Patients Initially Treated With Open Versus Minimally Invasive Liver Surgery: An Intention‐to‐Treat Analysis , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  A. Singal,et al.  Addition of [18F]Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography to Cross‐Sectional Imaging Improves Staging and Alters Management in Hepatocellular Carcinoma , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  Oumeima Laifa,et al.  Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides , 2020, Hepatology.

[8]  M. Sherman,et al.  Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients. , 2019, Journal of hepatology.

[9]  J. Fung,et al.  Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma. , 2019, Asian journal of surgery.

[10]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[11]  V. Bourcier,et al.  Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term Results , 2018, Liver Cancer.

[12]  A. Luciani,et al.  Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention‐to‐treat analysis , 2018, Hepatology.

[13]  G. Otto,et al.  Intention‐to‐treat survival benefit of liver transplantation in patients with hepatocellular cancer , 2017, Hepatology.

[14]  P. Nahon,et al.  Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. , 2017, Journal of hepatology.

[15]  P. Nahon,et al.  Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results. , 2016, Radiology.

[16]  V. Mazzaferro,et al.  Early Hepatocellular Carcinoma on the Procrustean Bed of Ablation, Resection, and Transplantation , 2014, Seminars in Liver Disease.

[17]  S. Imbeaud,et al.  A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. , 2013, Gastroenterology.

[18]  M. Zoli,et al.  Ten-Year Outcome of Radiofrequency Thermal Ablation for Hepatocellular Carcinoma: An Italian Experience , 2012, The American Journal of Gastroenterology.

[19]  F. Roudot-thoraval,et al.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.

[20]  V. Paradis,et al.  Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention‐to‐treat analysis , 2012, Hepatology.

[21]  P. Majno,et al.  Intention‐to‐treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation , 2011, Hepatology.

[22]  V. Paradis,et al.  57 BENEFIT OF RESECTION OF HCC FOLLOWED BY SALVAGE TRANSPLANTATION IN CASE OF RECURRENCE: AN INTENTION-TO-TREAT ANALYSIS , 2011 .

[23]  A. Luciani,et al.  Liver Resection for Transplantable Hepatocellular Carcinoma: Long-Term Survival and Role of Secondary Liver Transplantation , 2009, Annals of surgery.

[24]  J. Llovet,et al.  A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.

[25]  Luigi Solbiati,et al.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.

[26]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.

[27]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[28]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[29]  O. Seror,et al.  Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC. , 2017, Journal of hepatology.

[30]  E. Vicaut,et al.  Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis. , 2012, Journal of hepatology.

[31]  P. Bossuyt,et al.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. , 2012, The Lancet. Oncology.

[32]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.

[33]  G. Paumgartner,et al.  European Association for the Study of the Liver , 2006 .

[34]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.